- ￥800 - 2500
- 义翘神州
- 40143-R001
- 北京
- 2025年08月12日
- WB,ELISA
- 兔
- SARS-CoV/SARS-CoV-2
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
北京义翘神州科技股份有限公司
- 库存：
99
- 靶点：
Nucleocapsid
- 级别：
免疫检测
- 目录编号：
40143-R001
- 克隆性：
单克隆
- 抗原来源：
Monoclonal Rabbit IgG Clone #001
- 保质期：
12个月
- 抗体英文名：
SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb
- 抗体名：
SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody
- 标记物：
无
- 宿主：
兔
- 适应物种：
SARS-CoV/SARS-CoV-2
- 免疫原：
Monoclonal Rabbit IgG Clone #001
- 亚型：
IgG
- 形态：
液体
- 应用范围：
WB,ELISA
- 保存条件：
-20℃ to -80℃
- 浓度：
WB：1:1000-1:5000
- 规格：
50 µL/100 µL/20 µL
| 规格： | 50 µL | 产品价格： | ￥1500.0 |
|---|---|---|---|
| 规格： | 100 µL | 产品价格： | ￥2500 |
| 规格： | 20 µL | 产品价格： | ￥800 |
SARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb General Information
Product nameSARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb
Validated applicationsWB,ELISA
Application notesIHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
SpecificitySARS Coronavirus Nucleocapsid
Has cross-reactivity in ELISA and WB with
SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (Cat# 40588-V08B)
No cross-reactivity in ELISA with
MERS-CoV Nucleoprotein protein (40068-V08B)
HCoV-229E Nucleoprotein protein (40640-V07E)
HCoV-NL63 Nucleoprotein protein (40641-V07E)
HCoV-HKU1(isolate N5) Nucleoprotein protein (40642-V07E)
HCoV-OC43 Nucleoprotein (40643-V07E)
ImmunogenRecombinant SARS-CoV Nucleoprotein / NP Protein (Catalog#40143-V08B)
PreparationThis product is a recombinant monoclonal antibody expressed from HEK293 cells.
SourceMonoclonal Rabbit IgG Clone #001
PurificationProtein A
Formulation0.2 μm filtered solution in PBS
ConjugateUnconjugated
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
北京义翘神州科技股份有限公司（Sino Biological Inc.）创建于2007年，是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司，主要业务包括重组蛋白、抗体、基因和培养基等产品，以及重组蛋白、抗体的开发和生物分析检测等服务。
义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务，能够覆盖生命科学研究的多个领域，为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供“一站式”生物试剂产品和技术服务。客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲等地建立了子公司，在上海建立分公司，已成为生物试剂行业国内领先的科技公司之一。
凭借多年病毒蛋白研究技术优势，义翘神州仅用11天就成功表达出新冠病毒重要靶点受体结合域蛋白。为了更好的支持新冠病毒研究，义翘神州已开发生产近百种新冠病毒相关科研试剂，包括重要靶点抗原蛋白、中和抗体、抗原蛋白检测试剂盒等。义翘神州还可以提供新冠假病毒中和检测服务，可用于筛选出具有中和活性的抗体或血清，支持在细胞水平上的评估。目前，这些科研试剂已被全球数百家研究机构用于疫苗和抗体开发及基础机制研究。
Product nameSARS-CoV/SARS-CoV-2 Nucleocapsid Antibody, Rabbit MAb
Validated applicationsWB,ELISA
Application notesIHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
SpecificitySARS Coronavirus Nucleocapsid
Has cross-reactivity in ELISA and WB with
SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (Cat# 40588-V08B)
No cross-reactivity in ELISA with
MERS-CoV Nucleoprotein protein (40068-V08B)
HCoV-229E Nucleoprotein protein (40640-V07E)
HCoV-NL63 Nucleoprotein protein (40641-V07E)
HCoV-HKU1(isolate N5) Nucleoprotein protein (40642-V07E)
HCoV-OC43 Nucleoprotein (40643-V07E)
ImmunogenRecombinant SARS-CoV Nucleoprotein / NP Protein (Catalog#40143-V08B)
PreparationThis product is a recombinant monoclonal antibody expressed from HEK293 cells.
SourceMonoclonal Rabbit IgG Clone #001
PurificationProtein A
Formulation0.2 μm filtered solution in PBS
ConjugateUnconjugated
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
北京义翘神州科技股份有限公司（Sino Biological Inc.）创建于2007年，是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司，主要业务包括重组蛋白、抗体、基因和培养基等产品，以及重组蛋白、抗体的开发和生物分析检测等服务。
义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务，能够覆盖生命科学研究的多个领域，为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供“一站式”生物试剂产品和技术服务。客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲等地建立了子公司，在上海建立分公司，已成为生物试剂行业国内领先的科技公司之一。
凭借多年病毒蛋白研究技术优势，义翘神州仅用11天就成功表达出新冠病毒重要靶点受体结合域蛋白。为了更好的支持新冠病毒研究，义翘神州已开发生产近百种新冠病毒相关科研试剂，包括重要靶点抗原蛋白、中和抗体、抗原蛋白检测试剂盒等。义翘神州还可以提供新冠假病毒中和检测服务，可用于筛选出具有中和活性的抗体或血清，支持在细胞水平上的评估。目前，这些科研试剂已被全球数百家研究机构用于疫苗和抗体开发及基础机制研究。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
1, Al-Dalahmah O, et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage.Acta neuropathologica communications, PubMed ID: 32847628
2, Matschke J, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.The Lancet. Neurology, PubMed ID: 33031735
3, Jacob F, et al. Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.Cell stem cell, PubMed ID: 33010822
4, Szabolcs M, et al. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues.Applied immunohistochemistry & molecular morphology : AIMM, PubMed ID: 33086222
5, Andrews MG, et al. Tropism of SARS-CoV-2 for Developing Human Cortical Astrocytes.bioRxiv : the preprint server for biology, PubMed ID: 33469577
6, Putcharoen O, et al. Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.PloS one, PubMed ID: 33577615
7, Xu X, et al. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study.Signal transduction and targeted therapy, PubMed ID: 34006847
8, Bennett RS, et al. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples.Viruses, PubMed ID: 34065987
9, Renuse S, et al. A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens.EBioMedicine, PubMed ID: 34229274
10, Avendaño-Ortiz J, et al. SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.Journal of immunology (Baltimore, Md. : 1950), PubMed ID: 34183364
11, Kudose S, et al. Longitudinal Outcomes of COVID-19-Associated Collapsing Glomerulopathy and Other Podocytopathies.Journal of the American Society of Nephrology : JASN, PubMed ID: 34670811
12, Duan X, et al. An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection.Cell reports, PubMed ID: 34731648
13, Bennett RP, et al. Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties.JCI insight, PubMed ID: 34807849
14, Maus A, et al. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides.Journal of proteome research, PubMed ID: 34779632
15, Golden JW, et al. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.mBio, PubMed ID: 35073750
16, Li Z, et al. Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.Cell metabolism, PubMed ID: 35150639
17, Mizutani M, et al. Pathologic and Neuropathologic Study of a Case of COVID-19.JMA journal, PubMed ID: 35224283
18, Tomris I, et al. Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns.PLoS pathogens, PubMed ID: 35255100
19, Wang Z, et al. SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies.Signal transduction and targeted therapy, PubMed ID: 35461307
20, Chong Z, et al. Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron.bioRxiv : the preprint server for biology, PubMed ID: 35118466
21, Zheng H, et al. Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques.Cell reports, PubMed ID: 35594870
22, Chong Z, et al. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron.Cell reports, PubMed ID: 35523172
23, Rosendal E, et al. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.mBio, PubMed ID: 35532162
24, Nicholson MW, et al. Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs.Pharmaceuticals (Basel, Switzerland), PubMed ID: 35745684
25, Wang L, et al. SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity.The Journal of cell biology, PubMed ID: 35674692
26, Vanderboom PM, et al. Machine Learning-Based Fragment Selection Improves the Performance of Qualitative PRM Assays.Journal of proteome research, PubMed ID: 35849720
27, Xue Y, et al. Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19.Viruses, PubMed ID: 35891384
28, Lee S, et al. Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant.Microbiology spectrum, PubMed ID: 36005818
29, Coler B, et al. Diminished Antiviral Innate Immune Gene Expression in the Placenta Following a Maternal SARS-CoV-2 Infection.American journal of obstetrics and gynecology, PubMed ID: 36126729
30, Khan M, et al. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients.Neuron, PubMed ID: 36446381
31, Lindqvist R, et al. A Syntenin Inhibitor Blocks Endosomal Entry of SARS-CoV-2 and a Panel of RNA Viruses.Viruses, PubMed ID: 36298757
32, Chen M, et al. Infection of SARS-CoV-2 causes severe pathological changes in mouse testis.Journal of genetics and genomics = Yi chuan xue bao, PubMed ID: 36494057
33, Que H, et al. Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment.Signal transduction and targeted therapy, PubMed ID: 36566328
34, Wang Y, et al. Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.Cell discovery, PubMed ID: 36609558
35, Higashi-Kuwata N, et al. Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.Nature communications, PubMed ID: 36841831
36, Emmi A, et al. Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei.NPJ Parkinson's disease, PubMed ID: 36781876
37, Massimo M, et al. Haemorrhage of human foetal cortex associated with SARS-CoV-2 infection.Brain : a journal of neurology, PubMed ID: 36642091
38, Qiu S, et al. Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine.Signal transduction and targeted therapy, PubMed ID: 36922500
39, Nchioua R, et al. Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1.Life science alliance, PubMed ID: 36977594
40, Dickey TH, et al. Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines.Cell reports, PubMed ID: 36943870
41, Alhammad YM, et al. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice.bioRxiv : the preprint server for biology, PubMed ID: 37066301
42, Byström JW, et al. At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, PubMed ID: 36995373
43, Yue M, et al. Coronaviral ORF6 protein mediates inter-organelle contacts and modulates host cell lipid flux for virus production.The EMBO journal, PubMed ID: 37218505
44, Van Slambrouck J, et al. Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients.EBioMedicine, PubMed ID: 37224768
45, Min YQ, et al. A new cellular interactome of SARS-CoV-2 nucleocapsid protein and its biological implications.Molecular & cellular proteomics : MCP, PubMed ID: 37211047
46, Burnap SA, et al. Cross-linking Mass Spectrometry Uncovers Interactions Between High-density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.Molecular & cellular proteomics : MCP, PubMed ID: 37343697
47, Alhammad YM, et al. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.Proceedings of the National Academy of Sciences of the United States of America, PubMed ID: 37607224
48, Addetia A, et al. Neutralization, effector function and immune imprinting of Omicron variants.Nature, PubMed ID: 37648855
49, Hirata Y, et al. Genomic analysis of SARS-CoV-2 in forensic autopsy cases of COVID-19.Journal of medical virology, PubMed ID: 37537838
50, Ford ES, et al. Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19.Nature immunology, PubMed ID: 38057617
51, Sasaki M, et al. Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model.EBioMedicine, PubMed ID: 38159532
52, Garvanska DH, et al. The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactions.EMBO reports, PubMed ID: 38177924
53, Uraki R, et al. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants.NPJ vaccines, PubMed ID: 38167505
54, Yang L, et al. SARS-CoV-2 infection causes dopaminergic neuron senescence.Cell stem cell, PubMed ID: 38237586
55, Nagasawa S, et al. Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses.PloS one, PubMed ID: 38536820
56, Wang W, et al. Digital Surface-Enhanced Raman Spectroscopy-Lateral Flow Test Dipstick: Ultrasensitive, Rapid Virus Quantification in Environmental Dust.Environmental science & technology, PubMed ID: 38452107
57, Du H, et al. Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis.Journal of genetics and genomics = Yi chuan xue bao, PubMed ID: 38447818
58, Jeong GU, et al. Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis.Experimental & molecular medicine, PubMed ID: 38816566
59, Liu B, et al. An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike.Cell reports, PubMed ID: 38805396
60, Komiya Y, et al. Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection.Biochimica et biophysica acta. Molecular basis of disease, PubMed ID: 39154794
61, Yabu H, et al. Janus-Type Immunofluorescent Probes and a Quantitative Immunoassay System.Langmuir : the ACS journal of surfaces and colloids, PubMed ID: 39145991
2, Matschke J, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.The Lancet. Neurology, PubMed ID: 33031735
3, Jacob F, et al. Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.Cell stem cell, PubMed ID: 33010822
4, Szabolcs M, et al. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues.Applied immunohistochemistry & molecular morphology : AIMM, PubMed ID: 33086222
5, Andrews MG, et al. Tropism of SARS-CoV-2 for Developing Human Cortical Astrocytes.bioRxiv : the preprint server for biology, PubMed ID: 33469577
6, Putcharoen O, et al. Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.PloS one, PubMed ID: 33577615
7, Xu X, et al. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study.Signal transduction and targeted therapy, PubMed ID: 34006847
8, Bennett RS, et al. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples.Viruses, PubMed ID: 34065987
9, Renuse S, et al. A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens.EBioMedicine, PubMed ID: 34229274
10, Avendaño-Ortiz J, et al. SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.Journal of immunology (Baltimore, Md. : 1950), PubMed ID: 34183364
11, Kudose S, et al. Longitudinal Outcomes of COVID-19-Associated Collapsing Glomerulopathy and Other Podocytopathies.Journal of the American Society of Nephrology : JASN, PubMed ID: 34670811
12, Duan X, et al. An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection.Cell reports, PubMed ID: 34731648
13, Bennett RP, et al. Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties.JCI insight, PubMed ID: 34807849
14, Maus A, et al. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides.Journal of proteome research, PubMed ID: 34779632
15, Golden JW, et al. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.mBio, PubMed ID: 35073750
16, Li Z, et al. Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.Cell metabolism, PubMed ID: 35150639
17, Mizutani M, et al. Pathologic and Neuropathologic Study of a Case of COVID-19.JMA journal, PubMed ID: 35224283
18, Tomris I, et al. Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns.PLoS pathogens, PubMed ID: 35255100
19, Wang Z, et al. SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies.Signal transduction and targeted therapy, PubMed ID: 35461307
20, Chong Z, et al. Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron.bioRxiv : the preprint server for biology, PubMed ID: 35118466
21, Zheng H, et al. Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques.Cell reports, PubMed ID: 35594870
22, Chong Z, et al. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron.Cell reports, PubMed ID: 35523172
23, Rosendal E, et al. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.mBio, PubMed ID: 35532162
24, Nicholson MW, et al. Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs.Pharmaceuticals (Basel, Switzerland), PubMed ID: 35745684
25, Wang L, et al. SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity.The Journal of cell biology, PubMed ID: 35674692
26, Vanderboom PM, et al. Machine Learning-Based Fragment Selection Improves the Performance of Qualitative PRM Assays.Journal of proteome research, PubMed ID: 35849720
27, Xue Y, et al. Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19.Viruses, PubMed ID: 35891384
28, Lee S, et al. Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant.Microbiology spectrum, PubMed ID: 36005818
29, Coler B, et al. Diminished Antiviral Innate Immune Gene Expression in the Placenta Following a Maternal SARS-CoV-2 Infection.American journal of obstetrics and gynecology, PubMed ID: 36126729
30, Khan M, et al. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients.Neuron, PubMed ID: 36446381
31, Lindqvist R, et al. A Syntenin Inhibitor Blocks Endosomal Entry of SARS-CoV-2 and a Panel of RNA Viruses.Viruses, PubMed ID: 36298757
32, Chen M, et al. Infection of SARS-CoV-2 causes severe pathological changes in mouse testis.Journal of genetics and genomics = Yi chuan xue bao, PubMed ID: 36494057
33, Que H, et al. Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment.Signal transduction and targeted therapy, PubMed ID: 36566328
34, Wang Y, et al. Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.Cell discovery, PubMed ID: 36609558
35, Higashi-Kuwata N, et al. Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.Nature communications, PubMed ID: 36841831
36, Emmi A, et al. Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei.NPJ Parkinson's disease, PubMed ID: 36781876
37, Massimo M, et al. Haemorrhage of human foetal cortex associated with SARS-CoV-2 infection.Brain : a journal of neurology, PubMed ID: 36642091
38, Qiu S, et al. Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine.Signal transduction and targeted therapy, PubMed ID: 36922500
39, Nchioua R, et al. Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1.Life science alliance, PubMed ID: 36977594
40, Dickey TH, et al. Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines.Cell reports, PubMed ID: 36943870
41, Alhammad YM, et al. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice.bioRxiv : the preprint server for biology, PubMed ID: 37066301
42, Byström JW, et al. At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, PubMed ID: 36995373
43, Yue M, et al. Coronaviral ORF6 protein mediates inter-organelle contacts and modulates host cell lipid flux for virus production.The EMBO journal, PubMed ID: 37218505
44, Van Slambrouck J, et al. Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients.EBioMedicine, PubMed ID: 37224768
45, Min YQ, et al. A new cellular interactome of SARS-CoV-2 nucleocapsid protein and its biological implications.Molecular & cellular proteomics : MCP, PubMed ID: 37211047
46, Burnap SA, et al. Cross-linking Mass Spectrometry Uncovers Interactions Between High-density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.Molecular & cellular proteomics : MCP, PubMed ID: 37343697
47, Alhammad YM, et al. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.Proceedings of the National Academy of Sciences of the United States of America, PubMed ID: 37607224
48, Addetia A, et al. Neutralization, effector function and immune imprinting of Omicron variants.Nature, PubMed ID: 37648855
49, Hirata Y, et al. Genomic analysis of SARS-CoV-2 in forensic autopsy cases of COVID-19.Journal of medical virology, PubMed ID: 37537838
50, Ford ES, et al. Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19.Nature immunology, PubMed ID: 38057617
51, Sasaki M, et al. Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model.EBioMedicine, PubMed ID: 38159532
52, Garvanska DH, et al. The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactions.EMBO reports, PubMed ID: 38177924
53, Uraki R, et al. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants.NPJ vaccines, PubMed ID: 38167505
54, Yang L, et al. SARS-CoV-2 infection causes dopaminergic neuron senescence.Cell stem cell, PubMed ID: 38237586
55, Nagasawa S, et al. Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses.PloS one, PubMed ID: 38536820
56, Wang W, et al. Digital Surface-Enhanced Raman Spectroscopy-Lateral Flow Test Dipstick: Ultrasensitive, Rapid Virus Quantification in Environmental Dust.Environmental science & technology, PubMed ID: 38452107
57, Du H, et al. Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis.Journal of genetics and genomics = Yi chuan xue bao, PubMed ID: 38447818
58, Jeong GU, et al. Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis.Experimental & molecular medicine, PubMed ID: 38816566
59, Liu B, et al. An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike.Cell reports, PubMed ID: 38805396
60, Komiya Y, et al. Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection.Biochimica et biophysica acta. Molecular basis of disease, PubMed ID: 39154794
61, Yabu H, et al. Janus-Type Immunofluorescent Probes and a Quantitative Immunoassay System.Langmuir : the ACS journal of surfaces and colloids, PubMed ID: 39145991
技术资料暂无技术资料 索取技术资料
文献支持
SARS-CoV/SARS-CoV-2 Nucleocapsid 兔单克隆抗体
￥800 - 2500
